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Abstract
Background: The clinical characteristics of Chlamydia trachomatis respiratory tract infections in
Japanese neonates were investigated.
Methods: Clinical, laboratory and microbiological characteristics of five infants with pneumonia
due to C. trachomatis in early neonatal period were analyzed.
Results: Only C. trachomatis was identified in 4 infants. Both C. trachomatis and cytomegalovirus
was identified in one. Wheezing, tachypnea and cyanosis were common in infants. Mothers of five
infants had negative chlamydial EIAs at 20 weeks of gestation.
Conclusions:  We identified five cases of C. trachomatis respiratory tract infections in early
neonatal period with the possibility of intrauterine infection. Targeted screening, early diagnosis,
and effective treatment of perinatal and neonatal chlamydial infections seems to be necessary
Background
Chlamydia trachomatis has been recognized as a pathogen
of nongonococcal urethritis, salpingitis, endocervicitis,
pelvic inflammatory disease, inclusion conjunctivitis of
neonates, follicular conjunctivitis of adults, infantile
pneumonia and associated diseases. [1] Genital or respi-
ratory tract chlamydial infections still have been recog-
nized as a major public health problem throughout the
world including Japan.
Pneumonia due to C. trachomatis is a disease limited for
the most part to infants less than 6 months of age. It has
been suggested that C. trachomatis infection in pregnant
women may be related to premature labor and to perina-
tal complications. Although transmission of the organism
from mothers to their infants generally occurs at the time
of delivery with passage of the infant through the infected
endocervix, the possibility of intrauterine infection at late
pregnancy has been reported.[2,3] Gencay and colleagues
[4] studied C. trachomatis infection in mothers with pre-
term delivery and intrauterine transmission of the infec-
tion to their offspring. Their results strongly suggest that
mothers and their preterm babies may benefit from
screening for active C. trachomatis infection.
Reported below, are the cases of C. trachomatis respiratory
tract infections in early neonatal period with the possibil-
ity of intrauterine infection. Clinical characteristics of C.
trachomatis  respiratory tract infections in Japanese ne-
onates were investigated.
Methods
Patients
Annually 150 to 200 neonates were admitted to the neo-
natal intensive care unit (NICU) of the Hokkaido Chil-
dren's Hospital and Medical Center, Otaru, Hokkaido,
Japan. Each year we screened 30 to 50 neonates who had
respiratory tract symptoms for chlamydial infections. Five
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neonates with C. trachomatis infection were admitted to
NICU during the time of January 1995 to December 2001.
Case 1 was a female born by vaginal delivery after 39
week's gestation with a birth weight 2605 g; Case 2 was
also female born after 40 week's gestation by Caesarean
section because of fetal distress with a birth weight of
3025 g. No asphyxia was found at birth and was no epi-
sode of premature rupture of membrane (PROM) in both
cases. Tachypnea or cyanosis developed days 3 and 13 in
Case 1 and 2 respectively. Case 3 was a male born by vag-
inal delivery after 37 week's gestation with a birth weight
of 2982 g; Case 4 was a female born after 33 week's gesta-
tion also by vaginal delivery with a birth weight of 3025 g.
There was an episode of meconium-stained amniotic fluid
with Case 3. Chorioamnionitis was found in the placenta
of Case 4. Wheeze and tachypnea developed within one
day after delivery in Case 4. Case 5 was a male born after
37 week's gestation also by vaginal delivery with a birth
weight of 3,714 g. Tachypnea and cyanosis developed
from day 1 in Case 5.
For all patients oxygen saturation was measured initially
and subsequently. Oxygen was administered when the ar-
terial hemoglobin oxygen saturation was <90% with the
use of nasopharyngeal catheters or nasal cannulas. Anaer-
obic cultures were included using unvented commercial
blood culture bottles and incubating a blood agar subcul-
ture under anaerobic conditions.
Five infants were admitted with an initial diagnosis of
pneumonia and associated complications. Chest radio-
graphs of Cases 1, 2, 3 and 4 on admission showed streaky
shadows and reticulogranular infiltrates over whole lung
without hyperinflation. That of Case 5 on admission
showed streaky shadow over the whole lung without hy-
perinflation. Blood examination of Cases 1 and 2 revealed
increased C-reactive protein (13.1 and 6.5 mg/dl) and hy-
perleukocytosis (18,700 and 31,200/µl) without
eosinophilia.
Blood examination of Cases 3 and 4 revealed normal or
slight increased C-reactive protein (0.10 and 0.00 mg/dl)
and hyperleukocytosis (38500/µl) in Case 4. Bacterial cul-
tures from throat, urine, blood, feces and cerebrospinal
fluid are all negative. Human cytomegalovirus (CMV) was
isolated from urine of Case 5. Serum IgG and IgM anti-
bodies against CMV were detected from maternal and in-
fantile sera. Other viruses such as respiratory syncytial
(RS) virus, influenza virus and enteroviruses were not
identified from clinical specimens obtained from these 5
infants. Blood examination revealed increased C-reactive
protein (2.90 mg/dl) and hyperleukocytosis (20, 800/µl)
without eosinophilia.
Microbiological Methods
Both nasopharyngeal and conjunctival swabs were col-
lected from 5 infants within 2 weeks after birth for antigen
detection and the polymerase chain reaction (PCR) study.
Endocervical swabs of mothers during pregnancy were
also obtained. The PCR assay to amplify Omp 1 gene and
restriction fragment length polymorphism (RFLP) analy-
sis were used to detect and distinguish serotypes from gen-
otypes of C. trachomatis as reported previously.[5,6] At the
first step, 1.4 kbp DNA fragment that is larger than a full
length of the Omp 1 gene was amplified. At the second
step for nested PCR, 1.2 kbp DNA fragment, a full length
of Omp 1 gene was amplified. Genotyping was performed
by Hinf I, Hind III and Hha I restriction analysis of ampli-
fied Omp 1.
A commercially available EIA test kit was also used to de-
tect genus-specific chlamydial antigens. [7,8] Maternal se-
rum, infantile serum and cord blood samples were
obtained for standard microimmunofluorescence (MIF)
assay to detect IgG and IgM antibodies against C.
trachomatis.[2]
Results
For all of the infants, one or more infectious agent was
identified. In 4 infants, only C. trachomatis was identified.
Both C. trachomatis and CMV was identified in Case 5. All
nasopharyngeal specimens tested for C. trachomatis by
PCR or EIA were positive. Diagnosis of C. trachomatis res-
piratory tract infections was made by antigen detection or
PCR assay in nasopharyngeal swabs and by the presence
of specific serum IgM antibodies by MIF. Of the 5 infants
diagnosed with chlamydial infection, 3 had elevated se-
rum IgM titers and specific IgM antibodies against C. tra-
chomatis in cord blood.
The serovars that we identified from nasopharyngeal
swabs of these infants by PCR-RFLP were E and H. C. tra-
chomatis  was identified by PCR or EIA in conjunctival
swabs obtained from 3 infants. The serovars we identified
from conjunctival swabs were identical with those ob-
tained from nasopharyngeal swabs. There was no associa-
tion between carriage of C. trachomatis in respiratory tract
and any other bacteremias.
After review of all the chest radiograms by the radiologists,
5 infants were considered to have radiologic pneumonia.
There were more female. Clinical, laboratory and micro-
biological findings of five cases were summarized in Table
1. Wheezing, tachypnea and cyanosis were more common
in patients with pneumonia, and apnea or retraction was
not common. C. trachomatis was associated with reduced
SaO2.BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/2
Page 3 of 5
(page number not for citation purposes)
Before admission none of the patients were receiving oral
or intravenous antibiotics. Treatment with ampicillin and
amikacin was initiated without success. Respiratory tract
symptoms and radiological appearance improved gradu-
ally after oral erythromycin (40 mg/kg/per day) or clari-
thromycin (15 mg/kg/per day) administration for total of
14 to 28 days respectively. We also obtained the results of
laboratory and microbiological examinations of mothers
of five infants with C. trachomatis infection. Antenatal
records were available for 5 infants, whose mothers were
screened for C. trachomatis by EIA test only at 20 weeks of
gestation. These mothers had negative chlamydial EIAs
(Table 2). None of the mothers received oral or intrave-
nous antibiotics administration during pregnancy.
Discussion
Maternal C. trachomatis infections during pregnancy may
cause a variety of perinatal and neonatal complications.
Epidemiological data suggested an association between
colonization of the genital tract by C. trachomatis and an
increased risk of preterm PROM.[9–11]C trachomatis may
lead to abortion through excessive maternal immunogen-
ic reaction to its heat shock protein 60 antigen. [12]
We evaluated the significance of detection of serum anti-
bodies to C. trachomatis by ELISA at different time of preg-
nancy for early diagnosis of perinatal complications. [13]
The incidence of perinatal complications was significantly
higher in IgG and IgA antibodies-positive pregnant wom-
en at 30 weeks of gestational age. This fact also may indi-
cate of maternal acquisition of re- or new chlamydial
infection in later part of pregnancy. Intrauterine C. tracho-
matis infections acquired near the time of labor was con-
sidered to be associated with perinatal complications.
During the last decade there has been increased interest in
possible pathogenic role of organisms that colonize the
airways of preterm infants and cause disease processes
that could be devastating in this age group.[14]C. tracho-
matis[1,15,16] has been studied in the context of the de-
velopment of bronchopulmonary dysplasia (BPD.) While
serological evidence has associated C. trachomatis with
BPD, cultures for C. trachomatis have failed to confirm
Table 1: Clinical, laboratory and microbiological findings of five cases
C a s e 12345
Sex F F M F F
Gestational age (weeks) 39 40 37 33 37
Birth weight (g) 2,605 3,025 2,982 2,265 3,714
Mode of delivery Vaginal Caesarean Vaginal Vaginal Vaginal
Apgar score at 1 min after birth 9 8 7 8 7
Age at onset (days after birth) 3 13 1 0 1
Symptoms at onset Tachypnea Cyanosis Wheeze Tachypnea Tachypnea
Nasopharyngeal chlamydial antigen + + + + +
Nasopharyngeal chlamydial DNA + + + + +
Conjunctival chlamydial DNA + - + + -
Identified serovar of C. trachomatis EEEEH
Specific serum IgM antibodies
Cord blood 1:128 <1:16 <1:16 1:32 1:32
21 days after birth 1:64 1:32 1:32 1:16 <1:16
Table 2: Maternal microbiological findings during pregnancy
Mother of Case 1 2 3 4 5
Premature rupture of membranes no no no no no
Findings of placenta unknown unknown unknown Chorioamnionitis normal
Presence of endocervical chlamydial antigen by EIA no no no no no
Presence of bacterial or viral vaginosis unknown unknown unknown unknown yes
Serum antibodies to C. trachomatis (20 week's gestation)
IgG 1:256 not tested not tested 1:256 1:256
IgM <1:16 not tested not tested 1:64 <1:16BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/2
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these data. [16,17] Additionally, C. trachomatis, Mycoplas-
ma hominis, and CMV have been implicated as etiologic
agents for the development of BPD, [1,15–17] which was
not supported by other findings.[14]
The serovars of C. trachomatis that we identified from Jap-
anese infants and pregnant women were similar to those
reported in other studies from non-trachoma-endemic ar-
eas of developed countries and were thought to be mainly
urogenital tract-origin. [5,6] Similar results were also ob-
tained from the study of adult inclusion conjunctivitis in
Japan. [18] Antigenic variations of C. trachomatis were
found among the strains from nasopharyngeal, conjuncti-
val and endocervical origins.
Erythromycin and clarithromycin were thought to be not
toxic for fetuses and effective for the treatment of endocer-
vical infection of C. trachomatis. Some serological variants
of C. trachomatis may have different pathogenicity or drug-
sensitivity from classic serotypes. Early diagnosis and ap-
propriate treatment of chlamydial infections may reduce
perinatal complications. Oral administration of erythro-
mycin or clarithromycin for the treatment of C. trachoma-
tis respiratory tract infection in early neonatal period was
also considered to be effective.
Antigen detection of C. trachomatis from the endocervix by
EIA has been utilized widely for the purpose of the screen-
ing of chlamydial infections during pregnancy. However,
chlamydial antigen was not detected by EIA from any en-
docervical specimens of mothers at 20 weeks of gestation.
These tests are easily performed and less costly but have
lower sensitivities than culture or PCR and have low pos-
itive predictive values in low prevalence populations such
as Japan.[19]
Time of onset of respiratory tract symptoms of five infants
in the present study was within 2 weeks after birth. One
infant was born by cesarean section. Diagnosis of neona-
tal chlamydial infections was obtained by antigen or DNA
detection from nasopharyngeal swabs and by detection of
serum IgG and IgM antibodies to C. trachomatis.[2,3]
Our results as well as other investigators [4] demonstrate
the clinical characteristics of C. trachomatis respiratory
tract infections among infants in early neonatal period.
Although the patients tested positive for C. trachomatis
may not always have been associated with obvious symp-
toms, it has major role in perinatal mortality.[20] Control
programs emphasizing targeted screening, early diagnosis,
and effective treatment will have led to an eventual de-
cline in the incidence of perinatal and neonatal chlamy-
dial infections. [21] Approaches to prevention and
treatment of chlamydial infections in pregnant women
and infants seem to be necessary, including new antimi-
crobial interventions and the development of a vaccine
strategy.
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